Kristin Baird

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 19:632-9. 2013
  2. pmc Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Blood Marrow Transplant 18:698-707. 2012
  3. pmc Chronic graft-versus-host disease (GVHD) in children
    Kristin Baird
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Pediatr Clin North Am 57:297-322. 2010
  4. pmc Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease
    Kristin Baird
    Pediatric Oncology Branch, Center for Cancer Research CCR, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Transfus Apher Sci 41:209-16. 2009
  5. pmc Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease
    Kathryn J Martires
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Blood 118:4250-7. 2011
  6. doi request reprint Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses
    Kathryn J Martires
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD 20892, USA
    Arch Dermatol 147:1081-6. 2011
  7. pmc Quantitative salivary proteomic differences in oral chronic graft-versus-host disease
    Carol W Bassim
    National Institute of Dental and Craniofacial Research, 10 Center Drive, room 5 2531, MSC 1470, Bethesda, MD 20892, USA
    J Clin Immunol 32:1390-9. 2012
  8. pmc A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change
    Sandra A Mitchell
    Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:1619-29. 2011
  9. pmc Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients
    Asha R Patel
    Dermatology Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
    Biol Blood Marrow Transplant 15:370-6. 2009
  10. pmc Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation
    Christian M Capitini
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:142-4. 2009

Collaborators

Detail Information

Publications15

  1. pmc National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 19:632-9. 2013
    ..In this population of severely affected patients, NIH lung score is the strongest predictor of poor overall survival, both alone and after adjustment for other important factors...
  2. pmc Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomas
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Blood Marrow Transplant 18:698-707. 2012
    ..Enhanced chemo- and radiosensitivity of tumors and normal tissues was observed posttransplantation...
  3. pmc Chronic graft-versus-host disease (GVHD) in children
    Kristin Baird
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Pediatr Clin North Am 57:297-322. 2010
    ....
  4. pmc Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease
    Kristin Baird
    Pediatric Oncology Branch, Center for Cancer Research CCR, National Cancer Institute NCI, National Institutes of Health NIH, Bethesda, MD, USA
    Transfus Apher Sci 41:209-16. 2009
    ..Here we review the experience of extracorporeal photo-apheresis for the treatment of steroid refractory acute and chronic graft versus host disease based on the current literature...
  5. pmc Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease
    Kathryn J Martires
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Blood 118:4250-7. 2011
    ..Widespread skin involvement is associated with significant functional impairment, distressing symptoms, and diminished survival. This trial is registered at http://www.clinicaltrials.gov as NCT00331968...
  6. doi request reprint Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses
    Kathryn J Martires
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, Bethesda, MD 20892, USA
    Arch Dermatol 147:1081-6. 2011
    ....
  7. pmc Quantitative salivary proteomic differences in oral chronic graft-versus-host disease
    Carol W Bassim
    National Institute of Dental and Craniofacial Research, 10 Center Drive, room 5 2531, MSC 1470, Bethesda, MD 20892, USA
    J Clin Immunol 32:1390-9. 2012
    ....
  8. pmc A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change
    Sandra A Mitchell
    Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:1619-29. 2011
    ..Research is needed to evaluate inter- and intrarater reliability in larger samples, and to evaluate these response criteria as predictors of outcomes in clinical trials...
  9. pmc Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients
    Asha R Patel
    Dermatology Branch, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
    Biol Blood Marrow Transplant 15:370-6. 2009
    ..A high index of suspicion for this adverse reaction in the post-alloHCT setting will prevent misdiagnosis and avoid inappropriate therapy for cGVHD...
  10. pmc Unusual sites of extraskeletal metastases of Ewing sarcoma after allogeneic hematopoietic stem cell transplantation
    Christian M Capitini
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Pediatr Hematol Oncol 31:142-4. 2009
    ..Further clinical trials are needed to evaluate the role for allogeneic SCT for this disease...
  11. ncbi request reprint Chronic graft versus host disease
    Kristin Baird
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1203, USA
    Curr Opin Hematol 13:426-35. 2006
    ..The purpose of this review is to overview this disease and highlight recent findings in the literature over the past year...
  12. pmc Hematopoietic stem cell transplantation for leukemia
    Alan S Wayne
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Pediatr Clin North Am 57:1-25. 2010
    ..The characteristics of these high-risk subgroups and the role of HSCT in childhood leukemias are discussed...
  13. doi request reprint Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and ther
    Rachel Rau
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1104, USA
    Pediatr Infect Dis J 27:265-8. 2008
    ..She was treated with acyclovir and subsequently developed VZV antigen-positive zoster. Detection of VZV DNA in blood may be useful for early diagnosis in immunocompromised hosts who present with zoster without skin lesions...
  14. pmc Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency
    Chimene Kesserwan
    Genetics and Molecular Biology Branch and the Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892 4442, USA
    J Allergy Clin Immunol 129:762-769.e1. 2012
    ..This malignancy is rarely diagnosed in childhood...
  15. pmc Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma
    Courtney D Fitzhugh
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Pediatr Blood Cancer 53:496-8. 2009
    ..Almost 5 years after the osteosarcoma diagnosis, the patient was diagnosed with a supratentorial PNET, which represents the first known case reported in a patient with osteosarcoma...